The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis

Clinical and Experimental Rheumatology

Volumn 19, Issue 1, 2001, Pages 4-8

  Herrick, A L ^a   Matucci Cerinic, M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Antioxidants; Oxidative stress; Raynaud's phenomenon; Systemic sclerosis

Indexed keywords

ALLOPURINOL; ANTIOXIDANT; AUTOANTIGEN; FREE RADICAL; LIPOSOME; NIFEDIPINE; PROBUCOL; SUPEROXIDE DISMUTASE; TOXIN; TRACE ELEMENT;

ATROPHY; AUTOIMMUNITY; BLOOD VESSEL TONE; CARDIOVASCULAR SYSTEM; CELL ACTIVATION; CHROMOSOME BREAKAGE; CLINICAL FEATURE; EDITORIAL; ENDOTHELIUM; ENDOTHELIUM INJURY; FIBROBLAST; FIBROSIS; HUMAN; IMMUNE SYSTEM; ISCHEMIA; LEUKOCYTE ACTIVATION; LIPID PEROXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; REPERFUSION INJURY; SYSTEMIC SCLEROSIS; TISSUE INJURY; VASCULAR DISEASE;

ANTIOXIDANTS; CHROMOSOME BREAKAGE; HUMANS; LIPID PEROXIDATION; OXIDATIVE STRESS; REPERFUSION INJURY; ROLE; SCLERODERMA, SYSTEMIC; TOXINS, BIOLOGICAL;

EID: 0035098516     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (46)

1. Pathogenesis of systemic sclerosis: A vascular hypothesis
2. Sequential dermal microvascular and perivascular changes in the development of scleroderma
3. Oxygen-derived free radicals in postischemic tissue injury
4. Hypoxic-reperfusion injury in the inflammed knee joint
5. Free radicals, antioxidants, and human disease: Curiosity, cause, or consequence?
6. A radical proposal for the pathogenesis of scleroderma
7. Superoxide radicals in feline intestinal ischemia
8. Reactive oxygen metabolites and reperfusion injury: Aberrant triggering of reticuloendohelial function
9. Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis
10. Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis
11. Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis
12. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients
13. Increased production of nitric oxide stimulated by interleukin-1b in peripheral blood mononuclear cells in patients with systemic sclerosis
14. Nitric oxide synthesis in peripheral blood mononuclear and polymorphonuclear cells from patients with systemic sclerosis
15. Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis
16. Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin
17. The nitric oxide paradox in systemic sclerosis. The beauty and the beast
18. From Raynaud's phenomenon to systemic sclerosis (scleroderma): Lack or exhaustion of adaptation?
19. Anomalies chromosomiques dans la sclerodermie generalisee. Etude de dix malades
20. Clastogenic activity in the plasma of scleroderma patients: A biomarker of oxidative stress
21. Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: Implications for pathogenesis
22. Scleroderma: A disease related to damaged proteins?
23. Lipid peroxidation: Its mechanism, measurement, and significance
24. Role of oxidized low density lipoprotein in atherogenesis
25. Abnormalities of erythrocyte membrane fluidity, lipid composition, and lipid peroxidation in systemic sclerosis
26. Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis
27. Oxidative stress in systemic sclerosis
28. Antibodies against oxidised low-density lipoproteins in systemic sclerosis
29. Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis
30. Oxygen-exacerbated bleomycin pulmonary toxicity
31. The toxic oil syndrome: A perspective on immunotoxicological mechanisms
32. White blood cell activation in Raynaud's phenomenon of systemic sclerosis and vibration white finger
33. Further evidence of increased polymorphonuclear cell activity in patients with Raynaud's phenomenon
34. Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon
35. Micronutrient antioxidant status in patients with primary Raynaud's phenomenon and systemic sclerosis
36. Difficulty in detecting reperfusion injury increment in oxidative stress among patients with primary Raynaud's phenomenon and systemic sclerosis
37. Dietary intake and nutritional status in patients with systemic sclerosis
38. Dietary intake of micronutrient antioxidants in relation to blood levels in patients with systemic sclerosis
39. Ascorbic acid absorption in patients with systemic sclerosis
40. Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma
41. 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases
42. Elevated plasma superoxide dismutase activity in patients with systemic sclerosis
43. Monocytes of patients with systemic sclerosis (scleroderma) spontaneously release in vitro increased amounts of superoxide anion
44. Effect of liposomal-encapsulated superoxide dismutase on active oxygen-related human disorders. A preliminary study
45. Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon
46. A double-blind placebo-controlled trial of antioxidant therapy in limited cutaneous systemic sclerosis